`

Oncolys BioPharma Inc

Biotechnology Research

Specialities :
Oncology
Oncolytic viral therapy
Emerging infectious diseases
And orphan drugs
revenue-icon Revenue
< 1M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Oncolys BioPharma Inc

What does Oncolys biopharma inc do?+

Oncolys BioPharma Inc. is a Tokyo-based bioventure established in Japan in March 2004. Its mission is to contribute to the advancement of medical science in the world through bringing innovation to the existing treatments for cancer and serious infectious diseases, using its virology-based new drug discovery technologies. The company operates in two business segments. Pharmaceutical Business segment is engaged in the research, development, manufacture and marketing of novel drugs. Its major pipeline Telomelysin (OBP-301), an oncolytic adenovirus immunotherapy is in clinical development targeting various types of solid tumors including melanoma , HCC and esophageal cancer. Along with Telomelysin, an anti-HIV...

What are Oncolys biopharma inc's specialties? +

Oncology,oncolytic viral therapy,emerging infectious diseases,and orphan drugs

What is Oncolys biopharma inc's industry? +

Oncolys biopharma inc operates in the Biotechnology research industry.

What is Oncolys biopharma inc's revenue? +

Oncolys biopharma inc's revenue is < 1m

What is Oncolys biopharma inc's company size? +

Oncolys biopharma inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.